LACEE KELLER: Open Payments
NPI 1417232059 · SCHAUMBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 30 payments from 7 companies in 2025. Trend: 2023 $303 · 2024 $313 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $237 |
| Lilly USA, LLC | 10 | $150 |
| ABBVIE INC. | 2 | $35 |
| Boston Scientific Corporation | 1 | $23 |
| VIVUS LLC | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: MOUNJARO, Rybelsus, Wegovy, Ozempic, RINVOQ, APOLLO ESG System, QSYMIA, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
